Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination.

Hanquet G, Krizova P, Valentiner-Branth P, Ladhani SN, Nuorti JP, Lepoutre A, Mereckiene J, Knol M, Winje BA, Ciruela P, Ordobas M, Guevara M, McDonald E, Morfeldt E, Kozakova J, Slotved HC, Fry NK, Rinta-Kokko H, Varon E, Corcoran M, van der Ende A, Vestrheim DF, Munoz-Almagro C, Latasa P, Castilla J, Smith A, Henriques-Normark B, Whittaker R, Pastore Celentano L, Savulescu C; SpIDnet/I-MOVE+ Pneumo Group.

Thorax. 2018 Oct 24. pii: thoraxjnl-2018-211767. doi: 10.1136/thoraxjnl-2018-211767. [Epub ahead of print]

2.

Reply to Theilacker et al.

Naucler P, Galanis I, Morfeldt E, Darenberg J, Örtqvist Å, Henriques-Normark B.

Clin Infect Dis. 2018 May 2;66(10):1642-1643. doi: 10.1093/cid/cix1115. No abstract available.

PMID:
29272334
3.

External Quality Assurance for Laboratory Identification and Capsular Typing of Streptococcus pneumoniae.

Slotved HC, Sheppard CL, Dalby T, van der Ende A, Fry NK, Morfeldt E, Nyholm O, Rokney A, Ron M, Siira L, Scott KJ, Smith A, Thom L, Toropainen M, Vestrheim DF.

Sci Rep. 2017 Oct 16;7(1):13280. doi: 10.1038/s41598-017-13605-8.

4.

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations.

Naucler P, Galanis I, Morfeldt E, Darenberg J, Örtqvist Å, Henriques-Normark B.

Clin Infect Dis. 2017 Nov 13;65(11):1780-1789. doi: 10.1093/cid/cix685.

5.

Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study.

Savulescu C, Krizova P, Lepoutre A, Mereckiene J, Vestrheim DF, Ciruela P, Ordobas M, Guevara M, McDonald E, Morfeldt E, Kozakova J, Varon E, Cotter S, Winje BA, Munoz-Almagro C, Garcia L, Castilla J, Smith A, Henriques-Normark B, Celentano LP, Hanquet G; SpIDnet group.

Lancet Respir Med. 2017 Aug;5(8):648-656. doi: 10.1016/S2213-2600(17)30110-8. Epub 2017 Mar 27.

PMID:
28359798
6.

Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden.

Lindstrand A, Galanis I, Darenberg J, Morfeldt E, Naucler P, Blennow M, Alfvén T, Henriques-Normark B, Örtqvist Å.

Vaccine. 2016 Aug 31;34(38):4565-4571. doi: 10.1016/j.vaccine.2016.07.031. Epub 2016 Jul 26.

7.

Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden.

Galanis I, Lindstrand A, Darenberg J, Browall S, Nannapaneni P, Sjöström K, Morfeldt E, Naucler P, Blennow M, Örtqvist Å, Henriques-Normark B.

Eur Respir J. 2016 Apr;47(4):1208-18. doi: 10.1183/13993003.01451-2015. Epub 2016 Jan 21.

8.

Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model.

Smidt M, Bättig P, Verhaegh SJ, Niebisch A, Hanner M, Selak S, Schüler W, Morfeldt E, Hellberg C, Nagy E, Lundberg U, Hays JP, Meinke A, Henriques-Normark B.

PLoS One. 2013 May 9;8(5):e64422. doi: 10.1371/journal.pone.0064422. Print 2013.

9.

Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia.

Naucler P, Darenberg J, Morfeldt E, Ortqvist A, Henriques Normark B.

Thorax. 2013 Jun;68(6):571-9. doi: 10.1136/thoraxjnl-2012-203106. Epub 2013 Feb 26.

PMID:
23442364
10.

A case of diphtheria in Sweden, October 2011.

Fredlund H, Norén T, Lepp T, Morfeldt E, Henriques Normark B.

Euro Surveill. 2011 Dec 15;16(50):20038.

11.

Pattern of accessory regions and invasive disease potential in Streptococcus pneumoniae.

Blomberg C, Dagerhamn J, Dahlberg S, Browall S, Fernebro J, Albiger B, Morfeldt E, Normark S, Henriques-Normark B.

J Infect Dis. 2009 Apr 1;199(7):1032-42. doi: 10.1086/597205.

PMID:
19203261
12.

Sortase-mediated assembly and surface topology of adhesive pneumococcal pili.

Fälker S, Nelson AL, Morfeldt E, Jonas K, Hultenby K, Ries J, Melefors O, Normark S, Henriques-Normark B.

Mol Microbiol. 2008 Nov;70(3):595-607. doi: 10.1111/j.1365-2958.2008.06396.x. Epub 2008 Sep 17.

13.

The influence of in vitro fitness defects on pneumococcal ability to colonize and to cause invasive disease.

Fernebro J, Blomberg C, Morfeldt E, Wolf-Watz H, Normark S, Normark BH.

BMC Microbiol. 2008 Apr 18;8:65. doi: 10.1186/1471-2180-8-65.

14.
15.

RrgA is a pilus-associated adhesin in Streptococcus pneumoniae.

Nelson AL, Ries J, Bagnoli F, Dahlberg S, Fälker S, Rounioja S, Tschöp J, Morfeldt E, Ferlenghi I, Hilleringmann M, Holden DW, Rappuoli R, Normark S, Barocchi MA, Henriques-Normark B.

Mol Microbiol. 2007 Oct;66(2):329-40. Epub 2007 Sep 10.

16.

Clonal success of piliated penicillin nonsusceptible pneumococci.

Sjöström K, Blomberg C, Fernebro J, Dagerhamn J, Morfeldt E, Barocchi MA, Browall S, Moschioni M, Andersson M, Henriques F, Albiger B, Rappuoli R, Normark S, Henriques-Normark B.

Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12907-12. Epub 2007 Jul 20.

17.

Capsular expression in Streptococcus pneumoniae negatively affects spontaneous and antibiotic-induced lysis and contributes to antibiotic tolerance.

Fernebro J, Andersson I, Sublett J, Morfeldt E, Novak R, Tuomanen E, Normark S, Normark BH.

J Infect Dis. 2004 Jan 15;189(2):328-38. Epub 2003 Dec 30.

PMID:
14722899
18.

Binding of human C4BP to the hypervariable region of M protein: a molecular mechanism of phagocytosis resistance in Streptococcus pyogenes.

Berggård K, Johnsson E, Morfeldt E, Persson J, Stålhammar-Carlemalm M, Lindahl G.

Mol Microbiol. 2001 Oct;42(2):539-51.

19.

Isolated hypervariable regions derived from streptococcal M proteins specifically bind human C4b-binding protein: implications for antigenic variation.

Morfeldt E, Berggård K, Persson J, Drakenberg T, Johnsson E, Lindahl E, Linse S, Lindahl G.

J Immunol. 2001 Oct 1;167(7):3870-7.

20.
21.
22.

Detection of the response regulator AgrA in the cytosolic fraction of Staphylococcus aureus by monoclonal antibodies.

Morfeldt E, Panova-Sapundjieva I, Gustafsson B, Arvidson S.

FEMS Microbiol Lett. 1996 Oct 1;143(2-3):195-201.

PMID:
8837472
23.

Transcriptional control of the agr-dependent virulence gene regulator, RNAIII, in Staphylococcus aureus.

Morfeldt E, Tegmark K, Arvidson S.

Mol Microbiol. 1996 Sep;21(6):1227-37.

PMID:
8898391
24.

Activation of alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII.

Morfeldt E, Taylor D, von Gabain A, Arvidson S.

EMBO J. 1995 Sep 15;14(18):4569-77.

25.

DNA hybridization for diagnosis of pertussis.

Reizenstein E, Morfeldt E, Granström G, Granström M, Löfdahl S.

Mol Cell Probes. 1990 Aug;4(4):299-306.

PMID:
2402250
26.

A DNA hybridization test for detection of Bordetella in nasopharyngeal specimens.

Reizenstein E, Morfeldt E, Gilljam G, Hallander HO, Löfdahl S.

Mol Cell Probes. 1990 Jun;4(3):211-21.

PMID:
2199823
27.

Cloning of a chromosomal locus (exp) which regulates the expression of several exoprotein genes in Staphylococcus aureus.

Morfeldt E, Janzon L, Arvidson S, Löfdahl S.

Mol Gen Genet. 1988 Mar;211(3):435-40.

PMID:
3285138

Supplemental Content

Loading ...
Support Center